A cautious approach to handling MABs is recommended

British Journal of Nursing

Volumn 24, Issue Sup16a, 2015, Pages S3-

  Meade, Liz ^a  

^a Tullamore General Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADVERSE EFFECTS; HEALTH CARE PERSONNEL; HUMAN; NEOPLASMS; NURSING; NURSING CARE; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; RISK ASSESSMENT; STANDARDS;

ANTIBODIES, MONOCLONAL; HEALTH PERSONNEL; HUMANS; NEOPLASMS; NURSING CARE; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 84964695845     PISSN: 09660461     EISSN: 20522819     Source Type: Journal    
DOI: 10.12968/bjon.2015.24.Sup16a.S3     Document Type: Editorial

References (2)

1. King J, Alexander M, Byrne J et al (2014) A review of the evidence for occupational exposure risks to novel anticancer agents—a focus on monoclonal antibodies. J Oncol Pharm Pract pii: 1078155214550729
2. National Institute for Occupational Safety and Health (NIOSH) (2014) NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014. http://tinyurl.com/nupgndv (accessed 7 July 2015)